GSK3B and fatty liver disease: Betaine administration with the high fat diet to prevent insulin resistance, as well as for 4 weeks to treat established fatty liver and insulin resistance, improved histological liver injury, improved glucose tolerance test, and improved hepatic insulin sensitivity as measured by insulin-stimulated activation of IRS1, Akt, and GSK3β.